Frequency of stent fracture as a cause of coronary restenosis after sirolimus-eluting stent implantation.

Stent fracture (SF) was suggested as a cause of restenosis after sirolimus-eluting stent (SES) implantation. This study was performed to evaluate the incidence and characteristics of SF to determine its contribution to restenosis in patients with in-stent restenosis (ISR) after SES implantation. From May 2003 to February 2006, SESs were used for percutaneous coronary intervention in 868 patients with 1,109 coronary narrowings. Follow-up coronary angiography was performed in 366 patients (42%), and 26 ISR lesions were observed. These patients were enrolled in this study. SF was divided into 3 types as avulsion, collapse, and partial based on the findings of fluoroscopy, coronary angiography, and intravascular ultrasound study. Of 26 patients with ISR lesions, SF was identified in 10. SF types were avulsion (5 patients), collapse (2 patients), and partial (3 patients). SF was identified at the midshaft (7 patients) and overlap sites (3 patients) of stents. SF was not observed in the 30 patients with ISR after bare-metal Bx Velocity stent implantation. Four patients with SF were treated with paclitaxel-eluting stents. In conclusion, SF is 1 of the leading causes of ISR after SES implantation. Careful fluoroscopic examination is necessary at the time of follow-up angiography to identify this problem.

[1]  A. Colombo,et al.  Patterns of restenosis after drug-eluting stent implantation: Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents. , 2006, European heart journal.

[2]  M. Cowley.  Drug-Eluting Stent Restenosis: Incidence, Predictors, Mechanisms, and Treatment , 2006 .

[3]  Jong-Seon Park,et al.  Fractured DES with a patent coronary artery: clinical implications. , 2007, The Journal of invasive cardiology.

[4]  D. Dash,et al.  Stent strut fracture-induced restenosis in a bifurcation lesion treated with the crush stenting technique. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[5]  J. Moses,et al.  Quantitative Assessment of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Native Coronary Arteries , 2004, Circulation.

[6]  Seung‐Jung Park,et al.  Clinical and angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions. , 2006, The American journal of cardiology.

[7]  I. Iakovou,et al.  Early and Mid-Term Results of Drug-Eluting Stent Implantation in Unprotected Left Main , 2005, Circulation.

[8]  J. Popma,et al.  The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). , 2004, Journal of the American College of Cardiology.

[9]  Y. Yoon,et al.  Delayed strut fracture of sirolimus-eluting stent: a significant problem or an occasional observation? , 2006, International journal of cardiology.

[10]  P. Serruys,et al.  Two‐year clinical outcome after coronary stenting of small vessels using 2.25‐mm sirolimus‐ and paclitaxel‐eluting stents: Insight into the RESEARCH and T‐SEARCH registries , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.